about
Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation.Rapamycin treatment for a child with germline PTEN mutation.High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.β-blockers increase response to chemotherapy via direct antitumour and anti-angiogenic mechanisms in neuroblastoma.Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia.A Pilot Study of a Computerized Decision Support System to Detect Invasive Fungal Infection in Pediatric Hematology/Oncology Patients.Health-related quality of life of children on treatment for acute lymphoblastic leukemia: A systematic review.FBXW7 regulates glucocorticoid response in T-cell acute lymphoblastic leukaemia by targeting the glucocorticoid receptor for degradation.Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.Haematopoietic stem cell transplantation for primary immunodeficiency syndromes: A 5-year single-centre experience.Spinal Canal Involvement in Neuroblastoma.Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.Desensitisation to liposomal amphotericin B.MultiDimensional ClinOmics for Precision Therapy of Children and Adolescent Young Adults with Relapsed and Refractory Cancer: A Report from the Center for Cancer Research.False-positive MIBG scans with normal computed tomography imaging in patients with high-risk neuroblastoma.Adeno-associated virus and lentivirus vectors mediate efficient and sustained transduction of cultured mouse and human dorsal root ganglia sensory neurons.A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in children.Health-related quality of life of survivors of childhood acute lymphoblastic leukemia: a systematic review.Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia.Rare MYC-amplified Neuroblastoma With Large Cell Histology.Myosin light chain gene expression associated with disease states of the human heart.Too many targets, not enough patients: rethinking neuroblastoma clinical trials.Identification of plasma complement C3 as a potential biomarker for neuroblastoma using a quantitative proteomic approach.Xenograft-directed personalized therapy for a patient with post-transplant relapse of ALL.Recognition of Li Fraumeni syndrome at diagnosis of a locally advanced extremity rhabdomyosarcoma.Enrolment in paediatric oncology early-phase clinical trials: The health-care professionals' perspectiveIntegration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancerWDR5 Supports an N-Myc Transcriptional Complex That Drives a Protumorigenic Gene Expression Signature in NeuroblastomaAdenocarcinoma of the Lung in Childhood and Adolescence: A Systematic ReviewGoats' milk quackeryRituximab for lymphoproliferative disease prior to haematopoietic stem cell transplantation for X-linked severe combined immunodeficiencyPersistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemiaIncreased Survival for Children With Acute Myeloid Leukemia Results From Improved Postrelapse TreatmentAlectinib is effective, safe and tolerable in an adolescent with stage IVB ALK-rearranged adenocarcinoma of the lungJMJD1C-mediated metabolic dysregulation contributes to HOXA9-dependent leukemogenesisInhibition of polyamine synthesis and uptake reduces tumor progression and prolongs survival in mouse models of neuroblastomaRisk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemiaOptimization of a clofarabine-based drug combination regimen for the preclinical evaluation of pediatric acute lymphoblastic leukemiaAccelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapyMouse models of high-risk neuroblastoma
P50
Q34667915-8A1F191A-39E1-406B-AE55-DB688740C63EQ34773159-816CCA22-031E-4148-9F20-BA095B640C91Q35931599-16C0507A-CF57-4CA2-B7E9-3C7375BFCCF4Q36959073-7DEE566B-8D25-445D-8B0F-E7F01D17E9E7Q37952302-A0F0B007-2508-4315-9AA2-FE3770462295Q38567637-745A611E-3050-4D44-B154-E039F24030EBQ39165240-B803EB0A-A28D-4B6A-A1CC-296FA59A7F14Q39228542-7408F434-FC29-4D13-B3FC-EF684C8D9607Q39294214-C8EFE70F-A211-406B-AA43-8423BD6D4EBBQ40104469-79A52F7A-3B69-47E8-BC19-9A115F1E7046Q40147732-0B320C24-66B5-4D7C-84D8-0F54A1582507Q40308558-EADBA353-5DFA-4B85-8DAF-5902B03BAB77Q40505946-F73DB079-D77D-4C1A-A65C-5396DAA5FE69Q42385390-881E1279-3FCD-472A-B681-6FEEC11B3CBEQ43250049-206148F3-9777-4401-B618-94E964EAA51CQ44073196-93A990A6-2954-4605-91A8-7ECFA1186498Q47203054-9513BDC4-ECA6-4F16-BB19-000BDED6D624Q47645386-BE9D26E2-383B-49E6-8F3F-86B0358A2C17Q50042497-1C8EE994-C376-467C-B500-35A396D43818Q50094334-0C90F3C3-4A14-4223-83BB-398733D522D4Q52225341-47B6731B-380B-4786-89DB-BA45829C485AQ52597787-7D7742DF-B667-48FD-8551-B6B814ABB807Q53083996-E993EA05-423B-4ADA-AF06-705AEDA23DDFQ53100287-DED21E1F-EE19-405C-8729-56F5EAD5EC4EQ55470455-6870E3C5-B3DA-4192-8DDC-DCF0EE4B1247Q56983576-72659C0B-CB77-4109-A524-18D1894C5FE2Q57287736-F71A34B1-37A3-456B-B571-AC75F57D2E45Q58002180-9F91852D-0843-4572-BA38-6E8D389EAA33Q60456238-23FADA16-8A5D-40EA-8F51-265155DE0E02Q82201822-F943A56A-164A-4868-8377-41F009737789Q83866504-68B80089-1212-43E3-AE66-973185D718F1Q85777160-FBEF33AF-4988-4845-B0E2-DD1EC573C3EFQ88794748-7A12AAF9-89B8-4B33-A001-8325F0DE6756Q90334991-5A17F1CC-248D-496E-A377-DAA9086FA99DQ90949896-FE086CD6-BDAC-4064-BDA7-79C386019F04Q91283008-15DF6C50-EE47-46D4-92B1-32C75D0336DFQ91569787-F1D07F52-4EF5-4E90-A5F3-42EE0A035EC2Q92246017-68386501-704C-4125-B67F-7AEE9987A228Q92527643-1915A661-6661-42E3-883E-9E2D913CC89EQ92986764-519496EB-A3FB-4F52-88D3-75F7D057EE1A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Toby Trahair
@ast
Toby Trahair
@en
Toby Trahair
@es
Toby Trahair
@nl
Toby Trahair
@sl
type
label
Toby Trahair
@ast
Toby Trahair
@en
Toby Trahair
@es
Toby Trahair
@nl
Toby Trahair
@sl
prefLabel
Toby Trahair
@ast
Toby Trahair
@en
Toby Trahair
@es
Toby Trahair
@nl
Toby Trahair
@sl
P106
P1153
12772995200
P31
P496
0000-0002-3295-228X